Pre-transplant Bone Marrow Monocytic Myeloid-Derived Suppressor Cell Frequency Is Not Associated with Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Remission

Documenti analoghi

• Nonmyeloablative allogeneic hematopoietic cell transplantation
  di: Storb, Rainer, et al.
  Pubblicazione: (2016)
• Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia
  di: Araki, Daisuke, et al.
  Pubblicazione: (2015)
• Impact of Pre-Transplant Measurable Residual Disease on Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML
  di: Morsink, Linde M., et al.
  Pubblicazione: (2020)
• Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
  di: Morsink, Linde M., et al.
  Pubblicazione: (2020)
• Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission?
  di: Araki, Daisuke, et al.
  Pubblicazione: (2016)